News Details - Moderna
WEBMar 26, 2024 · The NEXTCove clinical trial is a randomized, observer-blind, active-controlled study of approximately 11,400 individuals aged 12 years and older in the United States, United Kingdom and Canada. mRNA-1283 was found to have a similar safety profile to Moderna's approved COVID-19 vaccines.
News Details - Moderna
WEBMar 27, 2024 · Announces positive clinical trial data from three new vaccines against viruses that cause significant burden (Epstein-Barr virus, Varicella-Zoster virus, norovirus) and advances programs toward Phase 3 development. Anticipates U.S. launch of vaccine against RSV following FDA approval and ACIP recommendation in 2024.
News Details - Moderna
WEBSep 11, 2023 · Moderna's updated COVID-19 vaccine contains spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older. With the U.S. FDA's decision, Moderna will begin shipping doses to vaccination sites across the U.S., with updated vaccines …
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAug 22, 2024 · FDA approved and authorized for emergency use updated mRNA COVID-19 vaccines (2024-2025 formula) to more closely target currently circulating variants to prevent COVID-19 and to provide better ...
News Details - Moderna
WEBJan 8, 2024 · Moderna enters 2024 with 45 therapeutic and vaccine programs, nine of which are in late-stage development. "In 2023, we achieved $6.7 billion in product sales and resized our COVID-19 manufacturing footprint for the endemic setting.
Combined COVID–flu vaccines are coming: Moderna jab clears
WEBJun 28, 2024 · Pharmaceutical laboratories are researching new applications for mRNA vaccine technology — and Moderna is hoping to integrate COVID-19, influenza and respiratory syncytial virus immunization ...
News Details - Moderna
WEBJun 10, 2024 · Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19. mRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines in adults 50 years and older, including an enhanced influenza vaccine in adults 65 years and older ...
Moderna Inc - The New York Times
WEBNews about Moderna Inc. Commentary and archival information about Moderna Inc from The New York Times.
Moderna says Covid-flu combination vaccine shows positive …
WEBJun 10, 2024 · Study results showed that in both age groups, the experimental combination vaccine elicited a statistically significant higher immune response against three strains of the flu and against Covid-19...
Moderna Says Its Booster Significantly Raises Antibodies …
WEBDec 20, 2021 · A booster shot of the Moderna coronavirus vaccine significantly raises the level of antibodies that can thwart the Omicron variant, the company announced on Monday. The news arrives as Omicron...
- Some results have been removed
Skip to content